Ryman Healthcare Limited (NZSE: RYM)
Health Care · Health Care Providers & Services · NZ
NZ$1.75
-1.96% today · -39.2% 1Y
Ryman Healthcare Limited (NZSE: RYM) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $993.68M and employs 7,800 people.
Over the last twelve months the share price has lost 39.2%, trading between 1.80 and 3.05.
Tweenvest scores Ryman Healthcare Limited across four factors: quality 60/100, value 64/100, growth 37/100. Its strongest factor is value.
RYM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $993.68M
- Revenue (TTM)
- $488.24M
- P/E
- —
- EPS
- -0.17
- Dividend yield
- —
- Beta (5Y)
- 0.37
- 52-week high
- NZ$3.05
- 52-week low
- NZ$1.80
- Avg volume (3M)
- —
- Shares outstanding
- 1.01B
- Employees
- 7,800
- Next earnings
- —
About Ryman Healthcare Limited
Ryman Healthcare Limited, established in Christchurch, New Zealand, in 1984, specializes in the development, ownership, and management of all-encompassing retirement communities for seniors. Operating across both New Zealand and Australia, the company provides a wide array of living and care solutions. These range from independent townhouses and apartments to serviced accommodations, complemented by dedicated care facilities offering residential, hospital, and specialized dementia care, alongside respite and day care services. Each of these integrated villages is equipped with extensive amenities, including indoor heated swimming pools, fitness centers, libraries, dining rooms, internet cafes, bars, retail outlets, movie theaters, bowling greens, and beauty and hairdressing salons. As of May 20, 2022, Ryman Healthcare oversaw 45 retirement villages, encompassing roughly 8,538 independent living units and 4,239 care beds.
- ISIN
- NZRYME0001S4
- Founded
- 1984
- Listed since
- Jun 28, 1999
- Exchange
- New Zealand Stock Exchange
- Currency
- NZD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc.NasdaqGS: LMRI | $1.02B | $10.33 | -2.46% |
| Clínica Baviera, S.A.BME: CBAV | $1.00B | €55.00 | -1.43% |
| Terveystalo OyjHLSE: TTALO | $1.00B | €7.00 | -0.71% |
| Life Healthcare Group Holdings LimitedJSE: LHC | $998.52M | R11.63 | -1.11% |
| Specialized Medical CompanySASE: 4019 | $992.81M | SR14.91 | -5.69% |
| Akso Health GroupNasdaqCM: AHG | $985.21M | $1.14 | -0.87% |
| Summerset Group Holdings LimitedNZSE: SUM | $984.84M | NZ$7.20 | -6.25% |
| Nanjing Pharmaceutical Group Company LimitedSHSE: 600713 | $975.11M | CN¥5.00 | +1.63% |
Figures last refreshed Oct 4, 2026.